Skip to main content
Back to RA Capital Management

RA Capital Management's Pharmaceutical Portfolio

Browse 82 Pharmaceutical companies funded by RA Capital Management. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
82
Total Funding in Pharmaceutical
$9.6B

Pharmaceutical Portfolio Companies (82)

Export
BiopharmaHealth CareMedicalPharmaceutical

ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.

San Diego, United States
September 2025
$100.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyDiabetesHealth CarePharmaceutical

KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.

Cambridge, United States
September 2025
$125.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.

Raleigh, United States
September 2024
$1.2M
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceutical

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Boston, United States
September 2023
$100.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

San Diego, United States
September 2025
$690.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

San Diego, United States
August 2025
$60.1M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.

New Haven, United States
August 2025
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

MedicalPharmaceuticalTherapeutics

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.

Dublin, Ireland
August 2025
$2.2M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

ManufacturingPharmaceutical

Sydnexis is engaged in the development of a proprietary treatment for pediatric progressive myopia.

Del Mar, United States
August 2021
$45.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceutical

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

South San Francisco, United States
July 2024
$175.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.

Boston, United States
July 2023
$60.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceuticalTherapeutics

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Del Mar, United States
July 2024
$30.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Radnor, United States
June 2026
$500.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceutical

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

Boston, United States
June 2026
$50.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareNeurosciencePharmaceuticalTherapeutics

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

Aurora, United States
June 2022
$40.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife SciencePharmaceuticalPrecision MedicineTherapeutics

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

San Francisco, United States
June 2024
$20.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMental HealthNeurosciencePharmaceutical

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

Toronto, Canada
June 2026
$50.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Cambridge, United States
June 2026
$200.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.

Cambridge, United States
June 2026
$50.0M
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalPrecision Medicine

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Cambridge, United States
June 2026
$75.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CarePharmaceutical

CervoMed a clinical-stage firm focused on discovering therapies for brain degenerative illnesses.

Boston, United States
June 2026
$10.5M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

AgTechBiotechnologyPharmaceutical

Pluton Biosciences tests and discovers microbes for the production of a variety of products, primarily pesticides, and pharmaceuticals.

Saint Louis, United States
May 2023
$16.5M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

Seattle, United States
May 2023
$67.8M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.

New York, United States
May 2026
$6.8M
Post-IPO Secondary

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.

Durham, United States
April 2026
$5.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

Cambridge, United States
April 2024
$160.5M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

Dublin, Ireland
April 2026
$117.5M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalNeurosciencePharmaceutical

Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.

Redmond, United States
April 2026
$110.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Wilmington, United States
April 2026
$90.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Ventus Therapeutics develops small molecule drugs that target autoimmune diseases, inflammatory diseases, and cancer.

Waltham, United States
April 2023
$150K
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.

Menlo Park, United States
March 2026
$40.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Natick, United States
March 2024
$182.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceutical

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Cambridge, United States
March 2026
$75.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

Bedford, United States
March 2024
$125.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife SciencePharmaceuticalTherapeutics

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

La Jolla, United States
March 2026
$75.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

Westlake Village, United States
February 2024
$150.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth DiagnosticsOncologyPharmaceutical

Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.

Somerville, United States
February 2025
Private Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.

Waltham, United States
February 2023
$15.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsHealth CarePharmaceutical

ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.

New York, United States
February 2026
$115.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedicalPharmaceutical

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Copenhagen, Denmark
October 2025
$157.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Portland, United States
September 2025
$95.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.

London, United Kingdom
September 2025
$32.0M
Series A

Founder Contacts

30,000+ verified contacts

DeliveryMedicalPharmaceutical

Spyglass Pharma provides medicine for ophthalmic diseases.

Aliso Viejo, United States
June 2025
$75.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

Boston, United States
April 2025
$59.2M
Series B

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceutical

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Cambridge, United States
September 2024
$40.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.

Boston, United States
September 2024
$120.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Seattle, United States
August 2024
$144.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

San Mateo, United States
May 2024
$182.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceutical

Phathom Pharmaceuticals is a biopharmaceutical company.

Florham Park, United States
January 2026
$130.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Boston, United States
December 2025
$350.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.

San Carlos, United States
January 2026
$1.6M
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.

San Francisco, United States
January 2025
$287.5M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Lexington, United States
December 2025
$120.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

La Jolla, United States
December 2024
$350.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Waltham, United States
December 2024
$30.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife SciencePharmaceuticalTherapeutics

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Richmond, United States
January 2026
$115.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Belite Bio is a clinical stage biopharmaceutical drug development company.

San Diego, United States
December 2025
$350.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceutical

Curie Therapeutics is a fully integrated next-generation radiopharmaceutical firm that combines ligand research and radiochemistry experts.

Boston, United States
December 2021
$75.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

Naarden, The Netherlands
December 2024
$452.6M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.

Charlottesville, United States
January 2025
$57.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

Cambridge, United States
January 2025
$92.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Waltham, United States
November 2025
$125.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CareMedicalPharmaceutical

Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.

New York, United States
November 2024
$215.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsNeurosciencePharmaceutical

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

New Haven, United States
November 2025
$200.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyManufacturingPharmaceuticalTherapeutics

ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.

Allschwil, Switzerland
November 2024
$181.4M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

San Jose, United States
October 2025
$60.3M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceutical

Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.

Laguna Hills, United States
October 2025
$19.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.

Boston, United States
October 2023
$450.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .

Beijing, China
August 2025
$12.7M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.

Redwood City, United States
June 2021
$15.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.

South San Francisco, United States
March 2021
$80.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.

San Diego, United States
March 2021
$100.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.

Cambridge, United States
February 2021
$80.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Kira Pharmaceuticals is a Biotechnology Research Company.

Hong Kong, Hong Kong
January 2021
$53.5M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.

Shanghai, China
October 2020
$310.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth DiagnosticsPharmaceutical

Akouos is a biotechnology company focusing on restoring and preserving hearing.

Boston, United States
March 2020
$105.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

Brisbane, United States
February 2020
$200.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical DeviceOncologyPharmaceuticalTherapeutics

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

Dallas, United States
February 2019
$150.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsPharmaceutical

CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular.

Chevy Chase, United States
May 2018
$49.0M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Medeor Therapeutics is a biotechnology company that dedicates to dedicates to the development of personalized cellular immunotherapies.

South San Francisco, United States
January 2018
$18.8M
Grant

Founder Contacts

30,000+ verified contacts

Health CareMedical DevicePharmaceutical

We transform the management of OUD to help people begin and sustain recovery.

Plymouth Meeting, United States
January 2018
$110.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Lumena Pharmaceuticals develops oral therapeutics for rare liver diseases to improve liver function and relieve disease symptoms.

San Diego, United States
March 2014
$45.0M
Series B

Founder Contacts

30,000+ verified contacts

Explore RA Capital Management's Full Portfolio

View all companies funded by RA Capital Management across every industry and funding stage.

View Full RA Capital Management Portfolio